Veracyte, Inc. (VCYT): Free Cash Flow
$126.63M
Year ended 2025-12-31
$165.99M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $126.63M | +98.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $63.81M | +86.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $34.26M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$1.01M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$37.00M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$12.55M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$5.99M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$15.39M | n/m | 2021-02-22, From 2018-01-01 |
| 2017-12-31 | -$25.67M | n/m | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | -$32.19M | n/m | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | -$33.13M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$29.66M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$20.49M | n/m | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | -$8.63M | n/m | 2015-03-25, From 2012-01-01 |
| 2011-12-31 | -$13.80M | n/a | 2014-03-20, From 2011-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 2025-12-31 | $126.63M | +98.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $28.33M | -22.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $66.89M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$124.21M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $15.71M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$233.07M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$299.92M | n/m |
| Natera, Inc. (NTRA) | 2025-12-31 | $109.11M | +57.6% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $88.30M | -62.8% |
Compare VCYT, CSTL, CAI, FLGT side by side · Screen every company in Services-Medical Laboratories ↗